Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Revance Therapeutics (NQ: RVNC )

3.265 -0.305 (-8.54%)
Streaming Delayed Price Updated: 12:30 PM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Revance Therapeutics

< Previous 1 2 3 4 5 6 7 8 9 Next >
Revance Provides Update on DaxibotulinumtoxinA for Injection Pre-Approval Inspection
From Revance Therapeutics, Inc.
Via Business Wire
Revance Reports First Quarter 2021 Financial Results, Provides Corporate Update
From Revance Therapeutics, Inc.
Via Business Wire
Revance to Release First Quarter 2021 Financial Results on Monday, May 10, 2021
From Revance Therapeutics, Inc.
Via Business Wire
Revance to Showcase Clinical Findings at The Aesthetic Meeting 2021 that Supports DaxibotulinumtoxinA’s 24-Week Long Duration Profile Across Multiple Female Age Cohorts
From Revance Therapeutics, Inc.
Via Business Wire
Revance Announces First Patient Enrolled for DaxibotulinumtoxinA in Glabellar Lines and Cervical Dystonia in China by Fosun Pharma
From Revance Therapeutics, Inc.
Via Business Wire
Revance to Present Data on DaxibotulinumtoxinA for Injection and Hyaluronic Acid Fillers at American Academy of Dermatology VMX Meeting 2021
From Revance Therapeutics
Via Business Wire
Revance to Participate in the 20th Annual Needham Virtual Healthcare Conference
From Revance Therapeutics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.